Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-10.5%/yr
vs +11.4%/yr prior
5Y CAGR
-0.5%/yr
Recent deceleration
Acceleration
-22.0pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $103.67M | +3.2% |
| 2024 | $100.48M | -16.1% |
| 2023 | $119.82M | -17.2% |
| 2022 | $144.75M | +13.7% |
| 2021 | $127.33M | +20.0% |
| 2020 | $106.08M | -16.9% |
| 2019 | $127.66M | +36.0% |
| 2018 | $93.87M | +14.3% |
| 2017 | $82.16M | +19.0% |
| 2016 | $69.03M | - |